​In an announcement on November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) revealed the new Maximum Fair Prices for 15 prescription drugs will reduce Medicare spending by 44% (about ...

S&P 500 healthcare recap: top gainers/losers plus key stories on Medicare refill costs, China GLP-1 price wars, and Molina’s Burry boost—read now.

Consumers must be proactive in asking about eligibility to avoid bills that could exceed $1,000 for a five-day supply, ...

At least 12% of adults in the U.S. have been prescribed a glucagon‐like peptide‐1 drug for one or multiple indications, but ...

The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for ...

Gestational diabetes rose from 58.2 to 79.3 per 1,000 live births from 2016 to 2024, with highest rates among American Indian ...

The Food and Drug Administration has approved Novo Nordisk’s once-daily Wegovy pill, the first oral GLP-1 medicine for ...

Low-income Californians who use Wegovy and similar weight loss drugs will lose their coverage in January. California and ...

They compensate providers such as doctors and hospitals on quality rather than volume of care, and they engage and assist ...

Lifesaver offered old Americans fails Why are so many Americans so unhealthy? Could it be because the health-care industry and average Americans themselves just don’t want to make the effort ...

The FDA approval comes as Ozempic-style drugs face heightened regulatory scrutiny. Medicines regulators have recently issued ...

December 24, 2025) - The Obesity Medicine Association (OMA) released its Position Statement on Medicare and Medicaid Coverage and Expanded Access to Obesity Medications, detailing the association's ...